NasdaqGS:GRALBiotechs
Is GRAIL (GRAL) Turning Superpower Partnership Into a Scalable Edge in Preventative Oncology?
In early April 2026, Superpower announced a partnership with GRAIL, Inc. to offer the Galleri multi-cancer early detection blood test through its preventative health platform, giving members nationwide access to screening for signals across more than 50 cancer types with integrated clinical support.
By embedding Galleri into a broader biomarker and AI-driven care model for both individuals and employer populations, the collaboration positions GRAIL’s test as part of a comprehensive early...